Details about the neuroanatomical projections from CA1 to TR

To view more data and metadata associated with each report, click on its ID.

Report IDSending structure Receiving structureProjection strengthTechniqueGeneral description projectionCollatorAssociated reference
88645 Field CA1Postpiriform transition area very lightbiotinylated dextran amine (BDA)
Many of other amygdaloid nuclei showed extremely light labeling (Fig. 4A–D). Collator note: Swanson Atlas Levels 31-32.
Kishi T., Tsumori T., Yokota S. & Yasui Y. , 2006
88691 Field CA1Postpiriform transition area lightbiotinylated dextran amine (BDA)
Collator note: at least several labeled terminals in the rostralmost TR. See Fig. 7D, Swanson Atlas Levels 31-32.
Kishi T., Tsumori T., Yokota S. & Yasui Y. , 2006
General description technique/protocol: In case R53, BDA was injected into a temporal portion of field CA1 that abuts on the rostral Sv (Fig. 1A). Collator note: injection completely included in the CA1, rostro-ventral. The injection site is annotated here onto Swanson Atlas Level 37 (-5.3 mm f

Further details associated to record number 88645:
Position of injection: rostro-ventral
Topological position of injection: is contained
Extension of injection outside: none
The injection was performed in: left hemisphere
Position of terminal field: rostral
Topological position of terminal field: is contained
Extension of terminal field outside: none
The terminal field was found: ipsilateral